DIAsource Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 85

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 2

DIAsource General Information

Description

Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious diseases. The company's focus lies in offering a panel of accurate, reliable assays that allow the performant detection and measurement of various forms of Vitamin D metabolites, as well as developing new antibodies and assays to measure relevant biomarkers, enabling clients to detect and monitor endocrine disorders and infectious and auto-immune diseases.

Contact Information

Formerly Known As
Biosource Europe, Medgenics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • Rue du Bosquet, 2
  • 1348 Louvain-la-Neuve
  • Belgium
+32 010 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DIAsource Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.

Request a free trial

DIAsource Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious dis
Diagnostic Equipment
Louvain-la-Neuve, Belgium
85 As of 2023
000.00 0000-00-00
000000000000

000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000 000000000
Puteaux, France
000 As of 0000
000.00
00000 0000-00-00
000000&0

0000 0

rud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
0000000000 000000000
Nehren, Germany
00 As of 0000
000.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DIAsource Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ELITechGroup Formerly PE-Backed Puteaux, France 000 000.00 000000&0
Hain Lifescience Corporate Backed or Acquired Nehren, Germany 00 000000&0
Accelerate Diagnostics Corporation Tucson, AZ 000 00000 000000000 00 00000
Nanomix Formerly VC-backed San Leandro, CA 00 000.00 000000000 000.00
BioGenex Laboratories Corporation Fremont, CA 000 0000000000
You’re viewing 5 of 30 competitors. Get the full list »

DIAsource Patents

DIAsource Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9322828-B2 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010 000000000 0
US-20130084585-A1 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010 000000000 0
AU-2011247621-A1 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010 0000000000
AU-2011247621-B2 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010 000000000 0
AU-2010236056-A1 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite Active 27-Oct-2009 G01N33/82
To view DIAsource’s complete patent history, request access »

DIAsource Executive Team (4)

Name Title Board Seat Contact Info
Béatrice de Borman Chief Executive Officer
Corentin Frippiat Financial Controller
Peter Kerckx International Sales & Marketing Director - Business Segment Manager Ria
You’re viewing 3 of 4 executive team members. Get the full list »

DIAsource Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DIAsource Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.

Request a free trial

DIAsource Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) 30-Jul-2018 000000000 Buildings and Property
Viro-Immun Diagnostics 01-Sep-2017 Merger/Acquisition Diagnostic Equipment
To view DIAsource’s complete investments and acquisitions history, request access »

DIAsource FAQs

  • When was DIAsource founded?

    DIAsource was founded in 1996.

  • Who is the CEO of DIAsource?

    Béatrice de Borman is the CEO of DIAsource.

  • Where is DIAsource headquartered?

    DIAsource is headquartered in Louvain-la-Neuve, Belgium.

  • What is the size of DIAsource?

    DIAsource has 85 total employees.

  • What industry is DIAsource in?

    DIAsource’s primary industry is Diagnostic Equipment.

  • Is DIAsource a private or public company?

    DIAsource is a Private company.

  • What is the current valuation of DIAsource?

    The current valuation of DIAsource is 000.00.

  • What is DIAsource’s current revenue?

    The current revenue for DIAsource is 00000.

  • Who are DIAsource’s investors?

    AnteoTech and Invitrogen have invested in DIAsource.

  • Who are DIAsource’s competitors?

    ELITechGroup, Hain Lifescience, Accelerate Diagnostics, Nanomix, and BioGenex Laboratories are some of the 30 competitors of DIAsource.

  • When was DIAsource acquired?

    DIAsource was acquired on 04-Sep-2017.

  • Who acquired DIAsource?

    DIAsource was acquired by BioVendor Laboratorni Medicina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »